Application: IHC
Clonality: Polyclonal
Host: Rabbit
Reactivity: Human
Protein Description: cysteine and glycine-rich protein 2
Gene Name: CSRP2
Alternative Gene Name: CRP2, LMO5, SmLIM
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000020186: 100%, ENSRNOG00000003772: 100%
Entrez Gene ID: 1466
Uniprot ID: Q16527
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Clonality: Polyclonal
Host: Rabbit
Reactivity: Human
Protein Description: cysteine and glycine-rich protein 2
Gene Name: CSRP2
Alternative Gene Name: CRP2, LMO5, SmLIM
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000020186: 100%, ENSRNOG00000003772: 100%
Entrez Gene ID: 1466
Uniprot ID: Q16527
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
| Cognate Antibody/Antigen for Anti CSRP2 pAb (ATL-HPA045617) | |
| Antigen | PrEST Antigen CSRP2 (ATL-APrEST82642) |
| Documents & Links for Anti CSRP2 pAb (ATL-HPA045617) | |
| Datasheet | Anti CSRP2 pAb (ATL-HPA045617) Datasheet (External Link) |
| Vendor Page | Anti CSRP2 pAb (ATL-HPA045617) at Atlas |
| Documents & Links for Anti CSRP2 pAb (ATL-HPA045617) | |
| Datasheet | Anti CSRP2 pAb (ATL-HPA045617) Datasheet (External Link) |
| Vendor Page | Anti CSRP2 pAb (ATL-HPA045617) |
| Citations for Anti CSRP2 pAb (ATL-HPA045617) – 3 Found |
| CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis. Oncotarget. 2016 Mar 22;7(12):13688-705. doi: 10.18632/oncotarget.7327. PubMed |
| Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2. Sci Rep. 2018 Jul 5;8(1):10191. doi: 10.1038/s41598-018-28637-x. PubMed |
| CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways. Theranostics. 2020 Sep 2;10(24):11063-11079. doi: 10.7150/thno.45674. eCollection 2020. PubMed |